Advanced Blockchain AG

  • WKN: A0M93V
  • ISIN: DE000A0M93V6
  • Land: Deutschland

Nachricht vom 04.10.2021 | 09:30

Advanced Blockchain AG Participates in Talisman seed funding round

DGAP-News: Advanced Blockchain AG / Key word(s): Cryptocurrency / Blockchain/Expansion
04.10.2021 / 09:30
The issuer is solely responsible for the content of this announcement.

Advanced Blockchain AG (Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6) has made another successful six-figure investment via a seed funding round in the Decentralized Finance (DeFi) project Talisman.

Recently, the Polkadot Web3 wallet Talisman closed a $2.35 million seed funding round with capital provided by Advanced Blockchain AG and other prominent investors in the space such as Hypersphere Ventures, Koji Capital and several anonymous Flex DApps investors.

Talisman ( is a community-owned wallet built for a multi-chain future. It allows users to take control of their crypto assets, leverage novel use cases enabled by Polkadot and help shape the future of the project via a social layer.

Group Chief Investment Officer and Managing Director of Advanced Blockchain AG, Simon Telian, states "The future of crypto is going to be multi-chain. We, as Advanced Blockchain AG, are actively shaping this expedient development by contributing capital and expertise to this sector."

With successful completion of the funding round, the Talisman team announced plans to expand while providing additional features to help users interact with the Polkadot - Kusama paraverse ecosystem.

This investment expands Advanced Blockchain's position in the DeFi sector, helping to build a multi-chain future and actively shaping open-source innovation.

Further information on Advanced Blockchain AG and its other projects and investments can be found at

04.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021